Low Back Ache, Low Back Pain, Nerve Pain, Peripheral Nerve Injuries, Peripheral Nervous System Diseases, Sciatica, Signs and Symptoms
Conditions
Keywords
Sciatica, Nerve pain, Low back pain
Brief summary
This study aims to verify if patients with nerve-related leg pain benefits from neurodynamic treatment over two weeks.
Detailed description
Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain. Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP. Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.
Interventions
All techniques will be executed in a pain-free way (grade III). Mild discomfort will be accepted, but it must subside as soon as the technique ends. * In the dynamic opener technique, patient will be positioned in side-lying, with the affected side upwards. The therapist will then perform grade III oscillations aiming to open the lumbar foramen; * In the side-lying slider, the patient will be in side-lying with the affected side upwards. A combination of knee and hip flexion and extension movements will produce sliding in the neural structures; * In the slump slider, the patient will be seated in slump position. Combinations between neck and knee movements will produce greater nerve excursion than the side-lying slider. Patients will perform the slump slider in a pain-free manner.
Sponsors
Study design
Eligibility
Inclusion criteria
* unilateral leg pain (Intensity ≥ 3) * Pain distal to the buttocks * Reproduction of symptoms and change in symptoms with structural differentiation (cervical return to neutral position or ankle dorsiflexion) with slump test;
Exclusion criteria
* cauda equina syndrome; * bilateral leg pain; * crossed Lasègue sign; * previous surgery in the lumbar spine; * inflammatory arthropathies; * malignancy * being in litigation or in work-compensation due to back and/or leg pain * being receiving physiotherapy treatment at the time of baseline assessment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Leg Pain Intensity | Two weeks after randomization | Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS) |
| Disability | Two weeks after randomization | Disability will be measured by the Oswestry Disability Index (ODI) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Leg pain Intensity | Four weeks after randomization | Leg Pain will me measured by a 0-10 Pain NRS |
| Disability | Four weeks after randomization | Disability will be measured by the Oswestry Disability Index (ODI) |
| Back pain intensity | Two weeks after randomization | Back Pain will me measured by an 0-10 Pain NRS |
| Distribution of Symptoms | Two weeks, Four weeks after randomization | Distribution of symptoms will me measured by a body diagram |
| Function | Two weeks, Four weeks after randomization | Function will be measured by the Patient-Specific Functional Scale (PSFS) |
| Global Perceived Effect | Two weeks, Four weeks after randomization | Global Perceived Effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale |
Countries
Brazil